FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Janaki Amin

Research Profile

Disorders

Geographic Areas

Chemicals & Drugs

Concepts & Ideas

Procedures

Living Beings

HIV-1

Co-author Network

Publications

TOP 3
Gail V Matthews; Kiat Ruxrungtham; Joseph Sasadeusz; Rachel J Ali; Janaki Amin; Anchalee Avihingsanon; Scott Bowden; Rachel Hammond; Sharon R Lewin; Margaret Littlejohn; Stephen L Locarnini; Gregory J Dore
Quantitative HBsAg and HBeAg predict hepatitis B seroconversion after initiation of HAART in HIV-HBV coinfected individuals.
Amit C Achhra; Janaki Amin; David A Cooper; Andrew E Grulich; Anthony D Kelleher; Matthew G Law; Julie Yeung
Changes in metabolic, inflammatory and coagulation biomarkers after HIV seroconversion - the Health in Men (HIM) Biomarker Substudy.
Hla-Hla Thein; Scott R Walter; Janaki Amin; Jacob George; Heather F Gidding; Matthew G Law; Gregory J Dore
Survival after diagnosis of hepatocellular carcinoma and potential impact of treatment in a hepatitis B or C infected cohort.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Janaki Amin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Gail V Matthews; Kiat Ruxrungtham; Joseph Sasadeusz; Rachel J Ali; Janaki Amin; Anchalee Avihingsanon; Scott Bowden; Rachel Hammond; Sharon R Lewin; Margaret Littlejohn; Stephen L Locarnini; Gregory J Dore
Quantitative HBsAg and HBeAg predict hepatitis B seroconversion after initiation of HAART in HIV-HBV coinfected individuals.
PloS one 2013;8(4):e61297.
2013: Amit C Achhra; Janaki Amin; David A Cooper; Andrew E Grulich; Anthony D Kelleher; Matthew G Law; Julie Yeung
Changes in metabolic, inflammatory and coagulation biomarkers after HIV seroconversion - the Health in Men (HIM) Biomarker Substudy.
Antiviral therapy 2013;18(3):355-9.
2012: Hla-Hla Thein; Scott R Walter; Janaki Amin; Jacob George; Heather F Gidding; Matthew G Law; Gregory J Dore
Survival after diagnosis of hepatocellular carcinoma and potential impact of treatment in a hepatitis B or C infected cohort.
Hepatology research : the official journal of the Japan Society of Hepatology 2012;42(12):1175-86.
2012: Damien V Cordery; Sean Emery; Anthony D Kelleher; Allison Martin; Janaki Amin; David A Cooper
The influence of HLA supertype on thymidine analogue associated with low peripheral fat in HIV.
AIDS (London, England) 2012;26(18):2337-44.
2012: Amit C Achhra; Janaki Amin; Haitao Chu; David A Cooper; David Dunn; Sean Emery; Joseph A Kovacs; Lewis H Kuller; Matthew G Law; Caroline Sabin
Reclassification of risk of death with the knowledge of D-dimer in a cohort of treated HIV-infected individuals.
AIDS (London, England) 2012;26(13):1707-17.
2012: Denise C Hsu; Thatri Iampornsin; Susanna Ip; Janaki Amin; Jintanat Ananworanich; Anchalee Avihingsanon; Michelle Bailey; David A Cooper; Craig Leeman; Sarah L Pett; Marshall Plit; Kiat Ruxrungtham; Sasiwimol Ubolyam; John J Zaunders; Anthony D Kelleher
A novel assay detecting recall response to Mycobacterium tuberculosis: Comparison with existing assays.
Tuberculosis (Edinburgh, Scotland) 2012;92(4):321-7.
2012: Heather F Gidding; Paul A W Haber; Matthew G Law; Graeme A Macdonald; George Ostapowicz; Joe J Sasadeusz; Martin Weltman; Janaki Amin; Jacob George; Gregory J Dore
Hepatitis C treatment outcomes in Australian clinics.
The Medical journal of Australia 2012;196(10):633-7.
2012: John M Murray; Kazuo Suzuki; John J Zaunders; Janaki Amin; Michelle Bailey; David Baker; Christoph Boesecke; David A Cooper; Sean Emery; Anthony D Kelleher; Kersten K Koelsch; Kristin McBride
Integrated HIV DNA accumulates prior to treatment while episomal HIV DNA records ongoing transmission afterwards.
AIDS (London, England) 2012;26(5):543-50.
2012: Alexander Swart; Janaki Amin; Lucinda Burns; Louisa Degenhardt; Andrew E Grulich; Limin Mao; Nicola S Meagher; Dianne L O'Connell; Deborah A Randall; Claire Vajdic
The importance of blood-borne viruses in elevated cancer risk among opioid-dependent people: a population-based cohort study.
BMJ open 2012;2(5):.
2012: Hila Haskelberg; Jennifer F Hoy; Janaki Amin; Andrew Carr; Peter R Ebeling; Sean Emery
Changes in bone turnover and bone loss in HIV-infected patients changing treatment to tenofovir-emtricitabine or abacavir-lamivudine.
PloS one 2012;7(6):e38377.
2012: Amit C Achhra; Janaki Amin; Jennifer Hoy; Tuti Merati; David Nolan; Thira Sirisanthana; Junko Tanuma; Michelle Giles
Differences in lipid measurements by antiretroviral regimen exposure in cohorts from Asia and australia.
AIDS research and treatment 2012;2012():246280.
2012: Yu Ming Paul Lam; Kristin L McBride; Janaki Amin; David A Cooper; Damien V Cordery; Anthony D Kelleher; Kersten K Koelsch
Switching virally suppressed, treatment-experienced patients to a raltegravir-containing regimen does not alter levels of HIV-1 DNA.
PloS one 2012;7(3):e31990.
2011: Helen Byakwaga; David A Cooper; Sean Emery; Martyn A French; Roger Garsia; Hila Haskelberg; Anthony D Kelleher; Mark Kelly; Sharon R Lewin; Damian F J Purcell; Janaki Amin; Mark A Boyd
Intensification of antiretroviral therapy with raltegravir or addition of hyperimmune bovine colostrum in HIV-infected patients with suboptimal CD4+ T-cell response: a randomized controlled trial.
The Journal of infectious diseases 2011;204(10):1532-40.
2011: Heather F Gidding; Janaki Amin; Gregory J Dore; Matthew G Law
Hospitalization rates associated with hepatitis B and HIV co-infection, age and sex in a population-based cohort of people diagnosed with hepatitis C.
Epidemiology and infection 2011;139(8):1151-8.
2011: Hla-Hla Thein; S R Walter; Janaki Amin; J George; Heather F Gidding; Matthew G Law; Gregory J Dore
Trends in incidence of hepatocellular carcinoma after diagnosis of hepatitis B or C infection: a population-based cohort study, 1992-2007.
Journal of viral hepatitis 2011;18(7):e232-41.
2011: Amit C Achhra; Jialun Zhou; Jun Yong Choi; Jennifer Hoy; Fujie Zhang; David J Templeton; Tuti Merati; Ian Woolley; Kathy Petoumenos; Janaki Amin
The Clinical Significance of CD4 Counts in Asian and Caucasian HIV-Infected Populations: Results from TAHOD and AHOD.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 2011;10(3):160-70.
2011: Scott R Walter; Hla-Hla Thein; Janaki Amin; Heather F Gidding; Kate Ward; Matthew G Law; Jacob George; Gregory J Dore
Trends in mortality after diagnosis of hepatitis B or C infection: 1992-2006.
Journal of hepatology 2011;54(5):879-86.
2011: Azar Kariminia; Kulkanya Chokephaibulkit; Joselyn Pang; Pagakrong Lumbiganon; Rawiwan Hansudewechakul; Janaki Amin; Nagalingeswaran Kumarasamy; Thanyawee Puthanakit; Nia Kurniati; Nik Khairulddin Nik Yusoff; Vonthanak Saphonn; Siew Moy Fong; Kamarul Razali; Revathy Nallusamy; Annette H Sohn; Virat Sirisanthana
Cohort profile: the TREAT Asia pediatric HIV observational database.
International journal of epidemiology 2011;40(1):15-24.
2011: Allison Martin; Janaki Amin; David Baker; Mark Bloch; Andrew Carr; David A Cooper; Sean Emery
Predictors of limb fat gain in HIV positive patients following a change to tenofovir-emtricitabine or abacavir-lamivudine.
PloS one 2011;6(10):e26885.
2011: Heather F Gidding; Gregory J Dore; Janaki Amin; Matthew G Law
Trends in all cause and viral liver disease-related hospitalizations in people with hepatitis B or C: a population-based linkage study.
BMC public health 2011;11():52.
2010: Allison Martin; Janaki Amin; David A Cooper; Andrew Carr; Anthony D Kelleher; Mark Bloch; David Baker; Ian Woolley; Sean Emery
Abacavir does not affect circulating levels of inflammatory or coagulopathic biomarkers in suppressed HIV: a randomized clinical trial.
AIDS (London, England) 2010;24(17):2657-63.
2010: Dianne Carey; Janaki Amin; Mark Boyd; Kathy Petoumenos; Sean Emery
Lipid profiles in HIV-infected adults receiving atazanavir and atazanavir/ritonavir: systematic review and meta-analysis of randomized controlled trials.
The Journal of antimicrobial chemotherapy 2010;65(9):1878-88.
2010: Amit C Achhra; Janaki Amin; Matthew G Law; Sean Emery; Jan Gerstoft; Fred M Gordin; Michael J Vjecha; James D Neaton; David A Cooper
Immunodeficiency and the risk of serious clinical endpoints in a well studied cohort of treated HIV-infected patients.
AIDS (London, England) 2010;24(12):1877-86.
2010: Heather F Gidding; Janaki Amin; Gregory J Dore; Kate Ward; Matthew G Law
Hospital-related morbidity in people notified with hepatitis C: a population-based record linkage study in New South Wales, Australia.
Journal of hepatology 2010;53(1):43-9.
2010: Henry Zheng; Fred Ehrlich; Janaki Amin
Economic evaluation of the direct healthcare cost savings resulting from the use of walking interventions to prevent coronary heart disease in Australia.
International journal of health care finance and economics 2010;10(2):187-201.
2010: Allison M Salmon; Ingrid van Beek; Janaki Amin; John Kaldor; Lisa Maher
The impact of a supervised injecting facility on ambulance call-outs in Sydney, Australia.
Addiction (Abingdon, England) 2010;105(4):676-83.
2010: Damien V Cordery; Karl Hesse; Janaki Amin; David A Cooper
Raltegravir and unboosted atazanavir dual therapy in virologically suppressed antiretroviral treatment-experienced HIV patients.
Antiviral therapy 2010;15(7):1035-8.
2010: Marina T van Leeuwen; Angela C Webster; Margaret R E McCredie; John H Stewart; Stephen P McDonald; Janaki Amin; John M Kaldor; Jeremy R Chapman; Claire Vajdic; Andrew E Grulich
Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study.
BMJ (Clinical research ed.) 2010;340():c570.
2009: Allison Martin; Mark Bloch; Janaki Amin; David Baker; David A Cooper; Sean Emery; Andrew Carr
Simplification of antiretroviral therapy with tenofovir-emtricitabine or abacavir-Lamivudine: a randomized, 96-week trial.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;49(10):1591-601.
2009: Claire Vajdic; Marina T van Leeuwen; Angela C Webster; Margaret R E McCredie; John H Stewart; Jeremy R Chapman; Janaki Amin; Stephen P McDonald; Andrew E Grulich
Cutaneous melanoma is related to immune suppression in kidney transplant recipients.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(8):2297-303.
2009: Marina T van Leeuwen; Andrew E Grulich; Angela C Webster; Margaret R E McCredie; John H Stewart; Stephen P McDonald; Janaki Amin; John M Kaldor; Jeremy R Chapman; Claire Vajdic
Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation.
Blood 2009;114(3):630-7.
2009: Allison M Salmon; Ingrid van Beek; Janaki Amin; Andrew Grulich; Lisa Maher
High HIV testing and low HIV prevalence among injecting drug users attending the Sydney Medically Supervised Injecting Centre.
Australian and New Zealand journal of public health 2009;33(3):280-3.
2009: K Razali; Janaki Amin; G J Dore; M G Law
Modelling and calibration of the hepatitis C epidemic in Australia.
Statistical methods in medical research 2009;18(3):253-70.
2009: Van T T Nguyen; Janaki Amin; Matthew G Law; Gregory J Dore
Predictors and survival in hepatitis B-related hepatocellular carcinoma in New South Wales, Australia.
Journal of gastroenterology and hepatology 2009;24(3):436-42.
2009: Marina T van Leeuwen; Andrew E Grulich; Stephen P McDonald; Margaret R E McCredie; Janaki Amin; John H Stewart; Angela C Webster; Jeremy R Chapman; Claire Vajdic
Immunosuppression and other risk factors for lip cancer after kidney transplantation.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(2):561-9.
2009: Andrew Carr; Janaki Amin
Efficacy and tolerability of initial antiretroviral therapy: a systematic review.
AIDS (London, England) 2009;23(3):343-53; discussion 355-6.
2009: Henry Zheng; Nicola Orsini; Janaki Amin; Alicja Wolk; Van Thi Thuy Nguyen; Fred Ehrlich
Quantifying the dose-response of walking in reducing coronary heart disease risk: meta-analysis.
European journal of epidemiology 2009;24(4):181-92.
2008: Gail V Matthews; Anchalee Avihingsanon; Sharon R Lewin; Janaki Amin; Rungsun Rerknimitr; Panusit Petcharapirat; Pip Marks; Joe Sasadeusz; David A Cooper; Scott Bowden; Stephen Locarnini; Kiat Ruxrungtham; Gregory J Dore
A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in Thailand.
Hepatology (Baltimore, Md.) 2008;48(4):1062-9.
2008: Van Thi Thuy Nguyen; Karina Razali; Janaki Amin; Matthew G Law; Gregory J Dore
Estimates and projections of hepatitis B-related hepatocellular carcinoma in Australia among people born in Asia-Pacific countries.
Journal of gastroenterology and hepatology 2008;23(6):922-9.
2007: Janaki Amin; Dianne O'Connell; Mark Bartlett; Elizabeth Tracey; John Kaldor; Matthew Law; Gregory J Dore
Liver cancer and hepatitis B and C in New South Wales, 1990-2002: a linkage study.
Australian and New Zealand journal of public health 2007;31(5):475-82.
2007: Joanne M Micallef; Virginia Macdonald; Marianne Jauncey; Janaki Amin; William D Rawlinson; Ingrid van Beek; John M Kaldor; Peter White; Gregory J Dore
High incidence of hepatitis C virus reinfection within a cohort of injecting drug users.
Journal of viral hepatitis 2007;14(6):413-8.
2007: Virginia Macdonald; Gregory J Dore; Janaki Amin; Ingrid van Beek
Predictors of completion of a hepatitis B vaccination schedule in attendees at a primary health care centre.
Sexual health 2007;4(1):27-30.
2007: Janaki Amin; M G Law; J Micallef; Marianne Jauncey; Ingrid van Beek; John M Kaldor; Gregory J Dore
Potential biases in estimates of hepatitis C RNA clearance in newly acquired hepatitis C infection among a cohort of injecting drug users.
Epidemiology and infection 2007;135(1):144-50.
2006: Janaki Amin; Matthew G Law; Mark Bartlett; John M Kaldor; Gregory J Dore
Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study.
Lancet 2006;368(9539):938-45.
2006: Janaki Amin; Gregory J Dore; Dianne L O'Connell; Mark Bartlett; Elizabeth Tracey; John M Kaldor; Matthew G Law
Cancer incidence in people with hepatitis B or C infection: a large community-based linkage study.
Journal of hepatology 2006;45(2):197-203.
2006: Alan Winston; Janaki Amin; Gillian Hales; David A Cooper; Sean Emery
Nonnucleoside reverse transcriptase inhibitor fold change or plasma concentration as a predictor of virological response over 48 weeks in highly treatment experienced HIV-positive individuals.
AIDS research and human retroviruses 2006;22(4):338-41.
2006: Alan Winston; Janaki Amin; Patrick W G Mallon; Debbie Marriott; Andrew Carr; David A Cooper; Sean Emery
Minor changes in calculated creatinine clearance and anion-gap are associated with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy.
HIV medicine 2006;7(2):105-11.
2006: Elizabeth Hamlyn; J McAllister; A Winston; B Sinclair; Janaki Amin; Andrew Carr; David A Cooper
Is screening for sexually transmitted infections in men who have sex with men who receive non-occupational HIV post-exposure prophylaxis worthwhile?
Sexually transmitted infections 2006;82(1):21-3.
2006: Dominic E Dwyer; Cassy Workman; Gillian Hales; Janaki Amin; David Cooper; John Miller
Enfuvirtide in HIV-1-infected individuals changing therapy to a nucleoside reverse transcriptase inhibitor sparing regimen: the ALLIANCE Study.
Antiviral therapy 2006;11(4):409-19.
2005: Alan Winston; Gillian Hales; Janaki Amin; Erno van Schaick; David A Cooper; Sean Emery
The normalized inhibitory quotient of boosted protease inhibitors is predictive of viral load response in treatment-experienced HIV-1-infected individuals.
AIDS (London, England) 2005;19(13):1393-9.
2005: Alan Winston; Mark Bloch; Andrew Carr; Janaki Amin; Patrick W G Mallon; John Ray; Debbie Marriott; David A Cooper; Sean Emery
Atazanavir trough plasma concentration monitoring in a cohort of HIV-1-positive individuals receiving highly active antiretroviral therapy.
The Journal of antimicrobial chemotherapy 2005;56(2):380-7.
2005: A Winston; J McAllister; Janaki Amin; D A Cooper; A Carr
The use of a triple nucleoside-nucleotide regimen for nonoccupational HIV post-exposure prophylaxis.
HIV medicine 2005;6(3):191-7.
2005: Andrew E Grulich; Philip Cunningham; Mee Ling Munier; Garrett Prestage; Janaki Amin; Clare Ringland; Denise Whitby; Susan Kippax; John M Kaldor; William D Rawlinson
Sexual behaviour and human herpesvirus 8 infection in homosexual men in Australia.
Sexual health 2005;2(1):13-8.
2004: Marianne Jauncey; Joanne M Micallef; Stuart Gilmour; Janaki Amin; Peter White; William D Rawlinson; John M Kaldor; Ingrid van Beek; Gregory J Dore
Clearance of hepatitis C virus after newly acquired infection in injection drug users.
The Journal of infectious diseases 2004;190(7):1270-4.
2004: Janaki Amin; M Kaye; S Skidmore; D Pillay; David A Cooper; Gregory J Dore
HIV and hepatitis C coinfection within the CAESAR study.
HIV medicine 2004;5(3):174-9.
2004: Allison Martin; Don E Smith; Andrew Carr; Clare Ringland; Janaki Amin; Sean Emery; Jennifer Hoy; Cassy Workman; Nicholas Doong; Judith Freund; David A Cooper
Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study.
AIDS (London, England) 2004;18(7):1029-36.
2004: Janaki Amin; Heather F Gidding; Gwendolyn Gilbert; Josephine Backhouse; John Kaldor; Gregory J Dore; Margaret Burgess
Hepatitis C prevalence--a nationwide serosurvey.
Communicable diseases intelligence quarterly report 2004;28(4):517-21.
2002: Andrew Carr; Cassy Workman; Don E Smith; Jennifer Hoy; Jeff Hudson; Nicholas Doong; Allison Martin; Janaki Amin; Judith Freund; Matthew Law; David A Cooper
Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial.
JAMA : the journal of the American Medical Association 2002;288(2):207-15.
2001: Janaki Amin; Gwendolyn L Gilbert; RG Escott; TC Heath; Margaret A Burgess
Hepatitis A epidemiology in Australia: national seroprevalence and notifications.
The Medical journal of Australia 2001;174(7):338-41.
2000: Peter McIntyre; Janaki Amin; Heather F Gidding; Brynley P Hull; Siranda Torvaldsen; A Tucker; Fiona Turnbull; Margaret Burgess
Vaccine preventable diseases and vaccination coverage in Australia, 1993-1998.
Communicable diseases intelligence 2000;24(9):276-7.
2000: Heather F Gidding; Janaki Amin; Peter B McIntyre
Notifications of vaccine preventable diseases in Australia. Quarterly report (January-March 2000).
Communicable diseases intelligence 2000;24(8):239-41.
2000: Peter McIntyre; Janaki Amin; Heather F Gidding; Brynley P Hull; Siranda Torvaldsen; A Tucker; Fiona Turnbull; Margaret Burgess
Vaccine preventable diseases and vaccination coverage in Australia, 1993-1998.
Communicable diseases intelligence 2000;Suppl():v-83.
1999: J Thomson; Ming Lin; L Halliday; G Preston; Peter McIntyre; Heather F Gidding; Janaki Amin; L Roberts; K Higgins; F Brooke; Alison Milton; E O'Brien; David Witteveen; S Crerar
Australia's notifiable diseases status, 1998. Annual report of the National Notifiable Diseases Surveillance System.
Communicable diseases intelligence 1999;23(11):277-305.
1999: Janaki Amin; M Wong
Measles-mumps-rubella immunisation, autism and inflammatory bowel disease: update.
Communicable diseases intelligence 1999;23(8):222.
1999: Janaki Amin; T Heath; S Morrell
Hepatitis A in Australia in the 1990s: future directions in surveillance and control.
Communicable diseases intelligence 1999;23(5):113-20.
1998: Janaki Amin; Peter B McIntyre; TC Heath
Measles vaccine, inflammatory bowel disease and pervasive developmental disorder: is there cause for concern?
Communicable diseases intelligence 1998;22(4):58-9.